Patents Assigned to Cizzle Biotechnology Limited
  • Use of a Fibrinogen Capture Agent to Detect a Ciz1 B-Variant
    Publication number: 20180306795
    Abstract: The present invention relates to the use of a fibrinogen capture agent or a fibrinogen detection agent in an assay to detect a Ciz1 b-variant.
    Type: Application
    Filed: October 14, 2016
    Publication date: October 25, 2018
    Applicant: Cizzle Biotechnology Limited
    Inventor: Dawn Alison Coverley
  • REPLICATION PROTEIN
    Publication number: 20160011200
    Abstract: This invention relates to a screening method for the identification of agents which modulate the activity of a DNA replication protein as a target for intervention in cancer therapy and includes agents which modulate said activity. The invention also relates to the use of the DNA replication protein, and its RNA transcripts in the prognosis and diagnosis of proliferative disease e.g., cancer.
    Type: Application
    Filed: February 5, 2015
    Publication date: January 14, 2016
    Applicant: CIZZLE BIOTECHNOLOGY LIMITED
    Inventor: Dawn Coverley
  • METHODS AND COMPOUNDS FOR THE DIAGNOSIS AND TREATMENT OF CANCER
    Publication number: 20130210663
    Abstract: The present invention provides for methods for use in the diagnosis and prognosis of cancer. The invention further provides to binding agents and kits for us e.g., in such methods. The present invention further relates to compositions, methods of making said compositions and methods of using the same, including use in the treatment and diagnosis of cancer, including lung, lymphoma, liver, thyroid and bladder cancer. Compositions of the present invention useful in the treatment of cancer include anti-sense and small inhibitory RNAs (siRNA).
    Type: Application
    Filed: August 4, 2011
    Publication date: August 15, 2013
    Applicant: Cizzle Biotechnology Limited
    Inventor: Dawn Alison Coverley
  • REPLICATION PROTEIN
    Publication number: 20110070591
    Abstract: This invention relates to a screening method for the identification of agents which modulate the activity of a DNA replication protein as a target for intervention in cancer therapy and includes agents which modulate said activity. The invention also relates to the use of the DNA replication protein, and its RNA transcripts in the prognosis and diagnosis of proliferative disease e.g., cancer.
    Type: Application
    Filed: September 22, 2010
    Publication date: March 24, 2011
    Applicant: CIZZLE BIOTECHNOLOGY LIMITED
    Inventor: Dawn COVERLEY
  • Replication protein
    Patent number: 7833702
    Abstract: This invention relates to a screening method for the identification of agents which modulate the activity of a DNA replication protein as a target for intervention in cancer therapy and includes agents which modulate said activity. The invention also relates to the use of the DNA replication protein, and its RNA transcripts in the prognosis and diagnosis of proliferative disease e.g., cancer.
    Type: Grant
    Filed: December 5, 2003
    Date of Patent: November 16, 2010
    Assignee: Cizzle Biotechnology Limited
    Inventor: Dawn Coverley